Name: Acute Care
Brand: ECRI
SKU: NIL
Availability: InStock
Rating: 4.6 (5 reviews)

ISMP Newsroom

ISMP

Media Inquiries

For media inquiries and interviews with ISMP's subject matter experts, please contact Renee Brehio at rbrehio@ismp.org.

All posts

Press Coverage

Press Coverage

ISMP Updates List of Error-Prone Medical Information

This article appeared on the Pharmacy Practice News website on April 24, 2024.

Press Coverage

Press Coverage

ISMP Updates List of Error-Prone Medical Abbreviations

This article appeared on the Becker’s Hospital Review website on April 22, 2024.

Press Coverage

Press Coverage

Prescription for Secrecy: Most pharmacies not required to report medication errors

This article appeared on the Channel 13 WTHR website on March 28, 2024.

Press Coverage

Press Coverage

The Top 10 Patient Safety Concerns in 2024

This article appeared on the Medical Economics website on March 14, 2024.

Press Coverage

Press Coverage

A Step Forward for Medical Safety: New Guidelines for 2024-2025 from ISMP

This article appeared on the MyChesCo website on February 26, 2024.

Press Coverage

Press Coverage

Medication Errors 2023: The Year in Review

This article appeared on the Pharmacy Practice News website on February 9, 2024.

Stay Connected

Get medication safety news, event invitations and updates straight to your inbox!

Social Media

View the Latest from ECRI

News

HANYS Marketplace partners with ECRI to improve patient safety and reduce preventable harm in healthcare

HANYS Marketplace® has partnered with ECRI, a nonprofit organization advancing the safety and quality of healthcare, to provide New York’s hospitals and health systems with evidence-based solutions...

News

ECRI Names Cottage Health Winner of 2026 Health Technology Excellence Award

Innovative blood management initiative recognized for reducing waste through proactive interfacility transfers. ECRI, a nonprofit organization advancing the safety and quality of healthcare, has ho...

News

ECRI & ISMP Statement in Response to PCAC Decision on Compounding Peptides

The FDA Pharmacy Compounding Advisory Committee (PCAC) decided to recommend adding most of the peptides under consideration during its July 23-24, 2026, meeting to the 503A Bulks List, despite subs...

View all